735 related articles for article (PubMed ID: 31823040)
1. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
[TBL] [Abstract][Full Text] [Related]
2. Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable-Prévention Primaire registry.
Defaye P; Boveda S; Klug D; Beganton F; Piot O; Narayanan K; Périer MC; Gras D; Fauchier L; Bordachar P; Algalarrondo V; Babuty D; Deharo JC; Leclercq C; Marijon E; Sadoul N;
Europace; 2017 Sep; 19(9):1478-1484. PubMed ID: 28340096
[TBL] [Abstract][Full Text] [Related]
3. Contemporary rates and outcomes of single- vs. dual-coil implantable cardioverter defibrillator lead implantation: data from the Israeli ICD Registry.
Leshem E; Suleiman M; Laish-Farkash A; Konstantino Y; Glikson M; Barsheshet A; Goldenberg I; Michowitz Y;
Europace; 2017 Sep; 19(9):1485-1492. PubMed ID: 27702848
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes of Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: Lessons from the Israeli ICD Registry.
Konstantino Y; Haim M; Boxer J; Goldenberg I; Feldman A; Michowitz Y; Glikson M; Suleiman M;
J Cardiovasc Electrophysiol; 2016 Jun; 27(6):718-23. PubMed ID: 26852908
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry.
Frommeyer G; Reinke F; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Eckardt L
Clin Res Cardiol; 2020 Apr; 109(4):508-512. PubMed ID: 31367999
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.
Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM
Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
[TBL] [Abstract][Full Text] [Related]
10. Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry.
Frommeyer G; Andresen D; Ince H; Maier S; Stellbrink C; Kleemann T; Seidl K; Hoffmann E; Zrenner B; Hochadel M; Senges J; Eckardt L
Heart Vessels; 2019 Jul; 34(7):1196-1202. PubMed ID: 30607538
[TBL] [Abstract][Full Text] [Related]
11. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
[TBL] [Abstract][Full Text] [Related]
12. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
13. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter-defibrillator lead failure: how weak is the link?
Brinker JA
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
[TBL] [Abstract][Full Text] [Related]
15. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
[TBL] [Abstract][Full Text] [Related]
16. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
17. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
[TBL] [Abstract][Full Text] [Related]
18. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR
Gleva MJ; Wang Y; Curtis JP; Berul CI; Huddleston CB; Poole JE
Am J Cardiol; 2017 Nov; 120(10):1891-1898. PubMed ID: 28917495
[TBL] [Abstract][Full Text] [Related]
19. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
[TBL] [Abstract][Full Text] [Related]
20. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study.
Deisenhofer I; Kolb C; Ndrepepa G; Schreieck J; Karch M; Schmieder S; Zrenner B; Schmitt C
J Cardiovasc Electrophysiol; 2001 Feb; 12(2):134-42. PubMed ID: 11232608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
